Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC PI3K/mTOR inhibitor-13 sodium | 2361009-23-4 | 98.1% | 464.40 g/mol | C20H13F2N5NaO3S | 10 MG
SDP

Catalog No. 5000286541
Encompass_Preferred

PI3K/mTOR inhibitor-13 sodium is an orally active small-molecule dual inhibitor of phosphoinositide 3-kinase (PI3K) and mTOR kinases provided as the sodium salt for preclinical research applications. It is used to probe PI3K/mTOR signaling in oncology and fibrotic disease models and is supplied in small research quantities with documented purity and supporting documentation.

  • Oral dual PI3K and mTOR kinase inhibitor.
  • High reported purity (98.13%).
  • Available in small research quantities, including a 10 mg vial.
  • Suitable for in vitro and in vivo preclinical studies.
  • Includes supporting documentation such as COA and SDS.

Catalog No. 50-002-86541 Supplier Medchemexpress LLC Supplier No. HY153120A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

PI3K/mTOR inhibitor-13 sodium is an orally active small-molecule dual inhibitor of phosphoinositide 3-kinase (PI3K) and mTOR kinases provided as the sodium salt for preclinical research applications. It is used to probe PI3K/mTOR signaling in oncology and fibrotic disease models and is supplied in small research quantities with documented purity and supporting documentation.

  • Oral dual PI3K and mTOR kinase inhibitor.
  • High reported purity (98.13%).
  • Available in small research quantities, including a 10 mg vial.
  • Suitable for in vitro and in vivo preclinical studies.
  • Includes supporting documentation such as COA and SDS.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.